Jesse Mez1, Daniel H Daneshvar2, Patrick T Kiernan1, Bobak Abdolmohammadi1, Victor E Alvarez3, Bertrand R Huber4, Michael L Alosco1, Todd M Solomon5, Christopher J Nowinski6, Lisa McHale7, Kerry A Cormier1, Caroline A Kubilus1, Brett M Martin8, Lauren Murphy1, Christine M Baugh9, Phillip H Montenigro1, Christine E Chaisson8, Yorghos Tripodis10, Neil W Kowall11, Jennifer Weuve12, Michael D McClean13, Robert C Cantu14, Lee E Goldstein15, Douglas I Katz16, Robert A Stern17, Thor D Stein18, Ann C McKee19. 1. Boston University Alzheimer's Disease and CTE Center, Boston University School of Medicine, Boston, Massachusetts2Department of Neurology, Boston University School of Medicine, Boston, Massachusetts. 2. Boston University Alzheimer's Disease and CTE Center, Boston University School of Medicine, Boston, Massachusetts3Department of Orthopaedic Surgery, Stanford University, Stanford, California. 3. Boston University Alzheimer's Disease and CTE Center, Boston University School of Medicine, Boston, Massachusetts4VA Boston Healthcare System, US Department of Veteran Affairs, Boston, Massachusetts5Department of Veterans Affairs Medical Center, Bedford, Massachusetts. 4. Boston University Alzheimer's Disease and CTE Center, Boston University School of Medicine, Boston, Massachusetts2Department of Neurology, Boston University School of Medicine, Boston, Massachusetts4VA Boston Healthcare System, US Department of Veteran Affairs, Boston, Massachusetts5Department of Veterans Affairs Medical Center, Bedford, Massachusetts. 5. Boston University Alzheimer's Disease and CTE Center, Boston University School of Medicine, Boston, Massachusetts. 6. Boston University Alzheimer's Disease and CTE Center, Boston University School of Medicine, Boston, Massachusetts6Concussion Legacy Foundation, Waltham, Massachusetts. 7. Concussion Legacy Foundation, Waltham, Massachusetts. 8. Boston University Alzheimer's Disease and CTE Center, Boston University School of Medicine, Boston, Massachusetts7Data Coordinating Center, Boston University School of Public Health, Boston, Massachusetts. 9. Interfaculty Initiative in Health Policy, Harvard University, Boston, Massachusetts9Division of Sports Medicine, Boston Children's Hospital, Boston, Massachusetts. 10. Boston University Alzheimer's Disease and CTE Center, Boston University School of Medicine, Boston, Massachusetts10Department of Biostatistics, Boston University, Boston, Massachusetts11School of Public Health, Boston University, Boston, Massachusetts. 11. Boston University Alzheimer's Disease and CTE Center, Boston University School of Medicine, Boston, Massachusetts2Department of Neurology, Boston University School of Medicine, Boston, Massachusetts4VA Boston Healthcare System, US Department of Veteran Affairs, Boston, Massachusetts12Department of Pathology, Boston University School of Medicine, Boston, Massachusetts. 12. School of Public Health, Boston University, Boston, Massachusetts13Department of Epidemiology, Boston University, Boston, Massachusetts. 13. School of Public Health, Boston University, Boston, Massachusetts14Department of Environmental Health, Boston University, Boston, Massachusetts. 14. Boston University Alzheimer's Disease and CTE Center, Boston University School of Medicine, Boston, Massachusetts2Department of Neurology, Boston University School of Medicine, Boston, Massachusetts6Concussion Legacy Foundation, Waltham, Massachusetts15Department of Neurosurgery, Emerson Hospital, Concord, Massachusetts. 15. Boston University Alzheimer's Disease and CTE Center, Boston University School of Medicine, Boston, Massachusetts2Department of Neurology, Boston University School of Medicine, Boston, Massachusetts12Department of Pathology, Boston University School of Medicine, Boston, Massachusetts16Department of Psychiatry, Boston University School of Medicine, Boston, Massachusetts17Department of Ophthalmology, Boston University School of Medicine, Boston, Massachusetts18Department of Biomedical Engineering, Boston University College of Engineering, Boston, Massachusetts19Department of Electrical and Computer Engineering, Boston University College of Engineering, Boston, Massachusetts. 16. Department of Neurology, Boston University School of Medicine, Boston, Massachusetts20Braintree Rehabilitation Hospital, Braintree, Massachusetts. 17. Boston University Alzheimer's Disease and CTE Center, Boston University School of Medicine, Boston, Massachusetts2Department of Neurology, Boston University School of Medicine, Boston, Massachusetts21Department of Neurosurgery, Boston University School of Medicine, Boston, Massachusetts22Department of Anatomy and Neurobiology, Boston University School of Medicine, Boston, Massachusetts. 18. Boston University Alzheimer's Disease and CTE Center, Boston University School of Medicine, Boston, Massachusetts4VA Boston Healthcare System, US Department of Veteran Affairs, Boston, Massachusetts5Department of Veterans Affairs Medical Center, Bedford, Massachusetts12Department of Pathology, Boston University School of Medicine, Boston, Massachusetts. 19. Boston University Alzheimer's Disease and CTE Center, Boston University School of Medicine, Boston, Massachusetts2Department of Neurology, Boston University School of Medicine, Boston, Massachusetts4VA Boston Healthcare System, US Department of Veteran Affairs, Boston, Massachusetts5Department of Veterans Affairs Medical Center, Bedford, Massachusetts12Department of Pathology, Boston University School of Medicine, Boston, Massachusetts23Boston University School of Medicine, Boston, Massachusetts.
Abstract
Importance: Players of American football may be at increased risk of long-term neurological conditions, particularly chronic traumatic encephalopathy (CTE). Objective: To determine the neuropathological and clinical features of deceased football players with CTE. Design, Setting, and Participants: Case series of 202 football players whose brains were donated for research. Neuropathological evaluations and retrospective telephone clinical assessments (including head trauma history) with informants were performed blinded. Online questionnaires ascertained athletic and military history. Exposures: Participation in American football at any level of play. Main Outcomes and Measures: Neuropathological diagnoses of neurodegenerative diseases, including CTE, based on defined diagnostic criteria; CTE neuropathological severity (stages I to IV or dichotomized into mild [stages I and II] and severe [stages III and IV]); informant-reported athletic history and, for players who died in 2014 or later, clinical presentation, including behavior, mood, and cognitive symptoms and dementia. Results: Among 202 deceased former football players (median age at death, 66 years [interquartile range, 47-76 years]), CTE was neuropathologically diagnosed in 177 players (87%; median age at death, 67 years [interquartile range, 52-77 years]; mean years of football participation, 15.1 [SD, 5.2]), including 0 of 2 pre-high school, 3 of 14 high school (21%), 48 of 53 college (91%), 9 of 14 semiprofessional (64%), 7 of 8 Canadian Football League (88%), and 110 of 111 National Football League (99%) players. Neuropathological severity of CTE was distributed across the highest level of play, with all 3 former high school players having mild pathology and the majority of former college (27 [56%]), semiprofessional (5 [56%]), and professional (101 [86%]) players having severe pathology. Among 27 participants with mild CTE pathology, 26 (96%) had behavioral or mood symptoms or both, 23 (85%) had cognitive symptoms, and 9 (33%) had signs of dementia. Among 84 participants with severe CTE pathology, 75 (89%) had behavioral or mood symptoms or both, 80 (95%) had cognitive symptoms, and 71 (85%) had signs of dementia. Conclusions and Relevance: In a convenience sample of deceased football players who donated their brains for research, a high proportion had neuropathological evidence of CTE, suggesting that CTE may be related to prior participation in football.
Importance: Players of American football may be at increased risk of long-term neurological conditions, particularly chronic traumatic encephalopathy (CTE). Objective: To determine the neuropathological and clinical features of deceased football players with CTE. Design, Setting, and Participants: Case series of 202 football players whose brains were donated for research. Neuropathological evaluations and retrospective telephone clinical assessments (including head trauma history) with informants were performed blinded. Online questionnaires ascertained athletic and military history. Exposures: Participation in American football at any level of play. Main Outcomes and Measures: Neuropathological diagnoses of neurodegenerative diseases, including CTE, based on defined diagnostic criteria; CTE neuropathological severity (stages I to IV or dichotomized into mild [stages I and II] and severe [stages III and IV]); informant-reported athletic history and, for players who died in 2014 or later, clinical presentation, including behavior, mood, and cognitive symptoms and dementia. Results: Among 202 deceased former football players (median age at death, 66 years [interquartile range, 47-76 years]), CTE was neuropathologically diagnosed in 177 players (87%; median age at death, 67 years [interquartile range, 52-77 years]; mean years of football participation, 15.1 [SD, 5.2]), including 0 of 2 pre-high school, 3 of 14 high school (21%), 48 of 53 college (91%), 9 of 14 semiprofessional (64%), 7 of 8 Canadian Football League (88%), and 110 of 111 National Football League (99%) players. Neuropathological severity of CTE was distributed across the highest level of play, with all 3 former high school players having mild pathology and the majority of former college (27 [56%]), semiprofessional (5 [56%]), and professional (101 [86%]) players having severe pathology. Among 27 participants with mild CTE pathology, 26 (96%) had behavioral or mood symptoms or both, 23 (85%) had cognitive symptoms, and 9 (33%) had signs of dementia. Among 84 participants with severe CTE pathology, 75 (89%) had behavioral or mood symptoms or both, 80 (95%) had cognitive symptoms, and 71 (85%) had signs of dementia. Conclusions and Relevance: In a convenience sample of deceased football players who donated their brains for research, a high proportion had neuropathological evidence of CTE, suggesting that CTE may be related to prior participation in football.
Authors: Ann C McKee; Brandon E Gavett; Robert A Stern; Christopher J Nowinski; Robert C Cantu; Neil W Kowall; Daniel P Perl; E Tessa Hedley-Whyte; Bruce Price; Chris Sullivan; Peter Morin; Hyo-Soon Lee; Caroline A Kubilus; Daniel H Daneshvar; Megan Wulff; Andrew E Budson Journal: J Neuropathol Exp Neurol Date: 2010-09 Impact factor: 3.685
Authors: Thor D Stein; Philip H Montenigro; Victor E Alvarez; Weiming Xia; John F Crary; Yorghos Tripodis; Daniel H Daneshvar; Jesse Mez; Todd Solomon; Gaoyuan Meng; Caroline A Kubilus; Kerry A Cormier; Steven Meng; Katharine Babcock; Patrick Kiernan; Lauren Murphy; Christopher J Nowinski; Brett Martin; Diane Dixon; Robert A Stern; Robert C Cantu; Neil W Kowall; Ann C McKee Journal: Acta Neuropathol Date: 2015-05-06 Impact factor: 17.088
Authors: Kevin F Bieniek; Owen A Ross; Kerry A Cormier; Ronald L Walton; Alexandra Soto-Ortolaza; Amelia E Johnston; Pamela DeSaro; Kevin B Boylan; Neill R Graff-Radford; Zbigniew K Wszolek; Rosa Rademakers; Bradley F Boeve; Ann C McKee; Dennis W Dickson Journal: Acta Neuropathol Date: 2015-10-30 Impact factor: 17.088
Authors: Bennet I Omalu; Steven T DeKosky; Ronald L Hamilton; Ryan L Minster; M Ilyas Kamboh; Abdulrezak M Shakir; Cyril H Wecht Journal: Neurosurgery Date: 2006-11 Impact factor: 4.654
Authors: I Litvan; J J Hauw; J J Bartko; P L Lantos; S E Daniel; D S Horoupian; A McKee; D Dickson; C Bancher; M Tabaton; K Jellinger; D W Anderson Journal: J Neuropathol Exp Neurol Date: 1996-01 Impact factor: 3.685
Authors: Jonathan D Cherry; Yorghos Tripodis; Victor E Alvarez; Bertrand Huber; Patrick T Kiernan; Daniel H Daneshvar; Jesse Mez; Philip H Montenigro; Todd M Solomon; Michael L Alosco; Robert A Stern; Ann C McKee; Thor D Stein Journal: Acta Neuropathol Commun Date: 2016-10-28 Impact factor: 7.801
Authors: Robert A Stern; Daniel H Daneshvar; Christine M Baugh; Daniel R Seichepine; Philip H Montenigro; David O Riley; Nathan G Fritts; Julie M Stamm; Clifford A Robbins; Lisa McHale; Irene Simkin; Thor D Stein; Victor E Alvarez; Lee E Goldstein; Andrew E Budson; Neil W Kowall; Christopher J Nowinski; Robert C Cantu; Ann C McKee Journal: Neurology Date: 2013-08-21 Impact factor: 9.910
Authors: Andrea L C Schneider; Elizabeth Selvin; Menglu Liang; Lawrence Latour; L Christine Turtzo; Silvia Koton; Josef Coresh; Thomas Mosley; Christopher T Whitlow; Yun Zhou; Dean F Wong; Geoffrey Ling; Rebecca F Gottesman Journal: J Neurotrauma Date: 2019-05-23 Impact factor: 5.269
Authors: Jennifer Lorigan; Hugh Kearney; Bryan Grimes; Josephine Heffernan; Alan Beausang; Jane Cryan; Michael A Farrell; Francesca M Brett Journal: Ir J Med Sci Date: 2018-11-30 Impact factor: 1.568
Authors: Joel Castellanos; Cheng Perng Phoo; James T Eckner; Lea Franco; Steven P Broglio; Mike McCrea; Thomas McAllister; Jenna Wiens Journal: Sports Med Date: 2021-03 Impact factor: 11.136
Authors: Steven W Zonner; Keisuke Ejima; Ciara C Fulgar; Carmen N Charleston; Megan E Huibregtse; Zachary W Bevilacqua; Keisuke Kawata Journal: JAMA Ophthalmol Date: 2019-03-01 Impact factor: 7.389
Authors: Jennifer S Albrecht; Gulam Muhammed Al Kibria; Christina R Greene; Patricia Dischinger; Gabriel E Ryb Journal: J Am Geriatr Soc Date: 2019-07-25 Impact factor: 5.562